Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx Healthcare's Total Liabilities for the quarter that ended in Mar. 2026 was 円36,797 Mil.
Olba DVx Healthcare's quarterly Total Liabilities
increased
from Sep. 2025 (円34,604.77 Mil) to Dec. 2025 (円35,958.09 Mil) and
increased
from Dec. 2025 (円35,958.09 Mil) to Mar. 2026 (円36,797.04 Mil).
Olba DVx Healthcare's annual Total Liabilities
increased
from Jun. 2024 (円31,863.50 Mil) to Jun. 2025 (円33,615.58 Mil) but then
declined
from Jun. 2025 (円33,615.58 Mil) to Jun. 2026 (円33,592.52 Mil).
Olba DVx Healthcare Total Liabilities Related Terms
Olba DVx Healthcare Total Liabilities Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Olba DVx Healthcare's Total Liabilities for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of 円36,797 Mil mean?
Olba DVx Healthcare (TSE:2689) has a Total Liabilities of 円36,797 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Olba DVx Healthcare and its competitors.
Is Olba DVx Healthcare's Total Liabilities too high?
Olba DVx Healthcare's current Total Liabilities is 円36,797 Mil. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's Total Liabilities compare to MCK and COR?
Olba DVx Healthcare's Total Liabilities of 円36,797 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Olba DVx Healthcare and its competitors. Olba DVx Healthcare's current Total Liabilities is 円36,797 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.52, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current Total Liabilities is 円36,797 Mil. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current Total Liabilities is 円36,797 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.52.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
Total Liabilities: 円36,797 Mil
GF Value™: 円2,164.52 vs. price of 円1,925.00 (11.1% below fair value)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
